glp 1 how to use To: GLP-1 Injections At-home GLP-1 Injections: A How-to

Lancet Infect Dis

E.CorraM

doi:10.1111/jcpp.14056

El 68% de los usuarios de GLP-1 informaron haber tomado un medicamento de marca desarrollado por gigantes farmacuticos como Novo Nordisk y Eli Lilly, incluidos Ozempic, Mounjaro o Zepbound, mientras que el 19% dijo haber tomado medicamentos preparados a medida no aprobados por la FDA

What clinicians consider when advising against GLP-1 use during breastfeeding Lack of large, controlled lactation safety trials Unknown effects on infant growth or neurodevelopment Uncertainty about effects on milk supply or composition Elective nature of GLP-1 therapy for weight loss Availability of safer alternatives after breastfeeding ends Why FDA and medical guidance remains cautious FDA and specialty guidance emphasize caution during breastfeeding for several consistent reasons: Insufficient data: FDA labeling states there are inadequate data on GLP-1 medication effects in breastfed infants.,, Milk supply unknowns: It is not known whether GLP-1 medications affect milk supply (volume) or milk composition., Infant vulnerability: Early infancy is a sensitive developmental period, increasing caution when medication effects are unknown. Elective vs essential use: For weight management, potential maternal benefit often does not outweigh theoretical infant risk.,, Do semaglutide and tirzepatide pass into breast milk